14-23359475-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_005864.4(EFS):​c.1003C>T​(p.Arg335Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000163 in 1,591,788 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R335L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00015 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00016 ( 1 hom. )

Consequence

EFS
NM_005864.4 missense

Scores

4
8
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.193

Publications

0 publications found
Variant links:
Genes affected
EFS (HGNC:16898): (embryonal Fyn-associated substrate) The protein encoded by this gene is a member of the CAS (CRK-associated substrate) family of adaptor proteins which typically serve as scaffolds for the assembly of larger signaling complexes. These complexes form at the cell surface where integrin binding leads to the subsequent phosphorylation of a CAS protein. Additional binding of SRC family kinases leads to CAS hyperphosphorylation and the creation of binding sites for CRK and other proteins that cause actin cytoskeleton reorganization. This gene plays a role in integrin-mediated cell attachment, spreading, and migration and also plays a role in both normal and malignant cellular transformation. This broadly expressed gene has been shown to play a role in neurite outgrowth and its expression in the thymus and lymphocytes is important for T cell maturation and the development of immunological self-tolerance. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14931554).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EFSNM_005864.4 linkc.1003C>T p.Arg335Trp missense_variant Exon 4 of 6 ENST00000216733.8 NP_005855.1 O43281-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EFSENST00000216733.8 linkc.1003C>T p.Arg335Trp missense_variant Exon 4 of 6 1 NM_005864.4 ENSP00000216733.3 O43281-1
EFSENST00000351354.3 linkc.724C>T p.Arg242Trp missense_variant Exon 3 of 5 1 ENSP00000340607.3 O43281-2
EFSENST00000429593.6 linkc.496C>T p.Arg166Trp missense_variant Exon 4 of 6 2 ENSP00000416684.2 O43281-3

Frequencies

GnomAD3 genomes
AF:
0.000152
AC:
23
AN:
151634
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.000782
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000201
AC:
45
AN:
223634
AF XY:
0.000213
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00217
Gnomad EAS exome
AF:
0.000628
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000140
Gnomad OTH exome
AF:
0.000365
GnomAD4 exome
AF:
0.000165
AC:
237
AN:
1440038
Hom.:
1
Cov.:
44
AF XY:
0.000144
AC XY:
103
AN XY:
715180
show subpopulations
African (AFR)
AF:
0.000152
AC:
5
AN:
32870
American (AMR)
AF:
0.0000238
AC:
1
AN:
41972
Ashkenazi Jewish (ASJ)
AF:
0.00234
AC:
58
AN:
24792
East Asian (EAS)
AF:
0.000280
AC:
11
AN:
39250
South Asian (SAS)
AF:
0.0000239
AC:
2
AN:
83698
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49634
Middle Eastern (MID)
AF:
0.00288
AC:
15
AN:
5210
European-Non Finnish (NFE)
AF:
0.000103
AC:
114
AN:
1103180
Other (OTH)
AF:
0.000522
AC:
31
AN:
59432
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000152
AC:
23
AN:
151750
Hom.:
0
Cov.:
30
AF XY:
0.000135
AC XY:
10
AN XY:
74182
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41378
American (AMR)
AF:
0.00
AC:
0
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3468
East Asian (EAS)
AF:
0.000784
AC:
4
AN:
5102
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4792
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
67828
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000433
Hom.:
0
Bravo
AF:
0.000162
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000260
AC:
2
ExAC
AF:
0.000185
AC:
22

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 13, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1003C>T (p.R335W) alteration is located in exon 4 (coding exon 4) of the EFS gene. This alteration results from a C to T substitution at nucleotide position 1003, causing the arginine (R) at amino acid position 335 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.66
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
22
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.56
D;.;.
Eigen
Uncertain
0.20
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.95
D;D;D
M_CAP
Uncertain
0.099
D
MetaRNN
Benign
0.15
T;T;T
MetaSVM
Benign
-0.45
T
MutationAssessor
Uncertain
2.3
M;.;.
PhyloP100
-0.19
PrimateAI
Pathogenic
0.83
D
PROVEAN
Uncertain
-4.0
D;D;D
REVEL
Benign
0.23
Sift
Pathogenic
0.0
D;D;D
Sift4G
Uncertain
0.0040
D;D;D
Polyphen
1.0
D;.;D
Vest4
0.63
MVP
0.83
MPC
0.54
ClinPred
0.26
T
GERP RS
1.2
Varity_R
0.29
gMVP
0.64
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147068550; hg19: chr14-23828684; COSMIC: COSV53734754; COSMIC: COSV53734754; API